JPH10273434A - Skin cleaner - Google Patents
Skin cleanerInfo
- Publication number
- JPH10273434A JPH10273434A JP9530697A JP9530697A JPH10273434A JP H10273434 A JPH10273434 A JP H10273434A JP 9530697 A JP9530697 A JP 9530697A JP 9530697 A JP9530697 A JP 9530697A JP H10273434 A JPH10273434 A JP H10273434A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- poe
- salt
- extract
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims description 45
- 229920002125 Sokalan® Polymers 0.000 claims description 27
- 230000000694 effects Effects 0.000 abstract description 17
- 239000000017 hydrogel Substances 0.000 abstract description 17
- 239000000203 mixture Substances 0.000 abstract description 17
- 229920003169 water-soluble polymer Polymers 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 8
- 229920000642 polymer Polymers 0.000 abstract description 8
- 239000000499 gel Substances 0.000 abstract description 6
- 125000000129 anionic group Chemical group 0.000 abstract description 4
- 238000004140 cleaning Methods 0.000 abstract description 4
- 230000002378 acidificating effect Effects 0.000 abstract description 3
- 229920002554 vinyl polymer Polymers 0.000 abstract description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical class NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 abstract 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 239000002689 soil Substances 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 48
- -1 p H regulators Substances 0.000 description 41
- 239000000284 extract Substances 0.000 description 39
- 235000014113 dietary fatty acids Nutrition 0.000 description 22
- 239000000194 fatty acid Substances 0.000 description 22
- 229930195729 fatty acid Natural products 0.000 description 22
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 239000004166 Lanolin Substances 0.000 description 13
- 235000019388 lanolin Nutrition 0.000 description 13
- 229940039717 lanolin Drugs 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 239000004359 castor oil Substances 0.000 description 11
- 235000019438 castor oil Nutrition 0.000 description 11
- 239000003599 detergent Substances 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 11
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 150000001768 cations Chemical class 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 229960005150 glycerol Drugs 0.000 description 8
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000006096 absorbing agent Substances 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000003760 tallow Substances 0.000 description 5
- 239000002562 thickening agent Substances 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 239000001593 sorbitan monooleate Substances 0.000 description 4
- 229940035049 sorbitan monooleate Drugs 0.000 description 4
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960000846 camphor Drugs 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 235000011069 sorbitan monooleate Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 235000017822 Melilotus officinalis Nutrition 0.000 description 2
- 240000000366 Melilotus officinalis Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 2
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- FCAXDVKLWVSHGT-KVVVOXFISA-N (z)-docos-13-enoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O FCAXDVKLWVSHGT-KVVVOXFISA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- DXMNMEWATKSWOT-UHFFFAOYSA-N 1-[2,3-di(nonyl)phenoxy]-2,3-di(nonyl)benzene Chemical compound CCCCCCCCCC1=CC=CC(OC=2C(=C(CCCCCCCCC)C=CC=2)CCCCCCCCC)=C1CCCCCCCCC DXMNMEWATKSWOT-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- IFBDFMPSOCGRKA-UHFFFAOYSA-N 1-octadecoxyoctadecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC IFBDFMPSOCGRKA-UHFFFAOYSA-N 0.000 description 1
- QQXJNLYVPPBERR-UHFFFAOYSA-N 1-phenyldecan-1-one Chemical compound CCCCCCCCCC(=O)C1=CC=CC=C1 QQXJNLYVPPBERR-UHFFFAOYSA-N 0.000 description 1
- 229940114069 12-hydroxystearate Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- XWZPJRNVELUELY-GDVGLLTNSA-N 2,3-dihydroxypropyl (2s)-5-oxopyrrolidine-2-carboxylate Chemical compound OCC(O)COC(=O)[C@@H]1CCC(=O)N1 XWZPJRNVELUELY-GDVGLLTNSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- MXVBVDSNBADJOC-UHFFFAOYSA-N 2-(4,5-dihydroimidazol-1-yl)-4-hydroxybutanoic acid;sodium Chemical compound [Na].OCCC(C(O)=O)N1CCN=C1 MXVBVDSNBADJOC-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- LNCJHVLXANMHHD-UHFFFAOYSA-N 2-[2-heptadecyl-1-(2-hydroxyethyl)-4,5-dihydroimidazol-1-ium-1-yl]acetate Chemical compound CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O LNCJHVLXANMHHD-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- QDHUJKQTILCXTA-UHFFFAOYSA-N 3-benzoyl-2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O QDHUJKQTILCXTA-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- WMNORUTYNGVDKW-UHFFFAOYSA-N 4-ethyl-2-[(4-methoxyphenyl)methylidene]octanoic acid;octyl 3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=C(OC)C=C1.CCCCC(CC)CC(C(O)=O)=CC1=CC=C(OC)C=C1 WMNORUTYNGVDKW-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- NXMKHXUMUTXJAV-UHFFFAOYSA-N OCC(O)CO.C(CCCCCCCC=C/CCCCCCCC)(=O)O.OCC(O)CO.C(CCCCCCCC=C/CCCCCCCC)(=O)O.C(CCCCCCCC=C/CCCCCCCC)(=O)O Chemical compound OCC(O)CO.C(CCCCCCCC=C/CCCCCCCC)(=O)O.OCC(O)CO.C(CCCCCCCC=C/CCCCCCCC)(=O)O.C(CCCCCCCC=C/CCCCCCCC)(=O)O NXMKHXUMUTXJAV-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- CMCJFUXWBBHIIL-UHFFFAOYSA-N Propylene glycol stearate Chemical class CC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CMCJFUXWBBHIIL-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- WLCFKPHMRNPAFZ-UHFFFAOYSA-M didodecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC WLCFKPHMRNPAFZ-UHFFFAOYSA-M 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- JMGZBMRVDHKMKB-UHFFFAOYSA-L disodium;2-sulfobutanedioate Chemical compound [Na+].[Na+].OS(=O)(=O)C(C([O-])=O)CC([O-])=O JMGZBMRVDHKMKB-UHFFFAOYSA-L 0.000 description 1
- UEPZRTHUJVFXDN-UHFFFAOYSA-L disodium;3-ethyl-2-hexyl-2-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCC(S(O)(=O)=O)(C([O-])=O)C(CC)C([O-])=O UEPZRTHUJVFXDN-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-M nonanoate Chemical compound CCCCCCCCC([O-])=O FBUKVWPVBMHYJY-UHFFFAOYSA-M 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- ZNYIJXQYUNSKDX-NTISSMGPSA-M sodium;hydron;(2s)-2-(tetradecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O ZNYIJXQYUNSKDX-NTISSMGPSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- JIVZKJJQOZQXQB-UHFFFAOYSA-N tolazoline Chemical compound C=1C=CC=CC=1CC1=NCCN1 JIVZKJJQOZQXQB-UHFFFAOYSA-N 0.000 description 1
- 229960002312 tolazoline Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、皮膚洗浄料に関す
る技術分野に属する発明である。さらに詳細には、皮膚
に塗擦した際に垢状の凝集物が発生する皮膚洗浄料に関
する技術分野に属し、皮膚の汚れの除去効果に優れ,洗
い流した後や拭き取った後の皮膚状態が滑沢性にも優れ
ると共に、汚れが除去される過程がより視覚的に実感さ
れ得る皮膚洗浄料に関する発明である。TECHNICAL FIELD [0001] The present invention belongs to the technical field related to skin cleansing agents. More specifically, it belongs to the technical field of skin cleansing agents that produce slimey aggregates when rubbed on the skin, and has an excellent effect of removing dirt from the skin, and has a smooth skin condition after rinsing or wiping. The present invention relates to a skin cleanser which has excellent properties and allows the user to visually feel the process of removing dirt.
【0002】[0002]
【従来の技術】皮膚の汚れを除去することはスキンケア
における最も基礎的なステップであり、非常に多くの剤
型の皮膚洗浄料が上市されている。具体的には、クレン
ジングフォーム,クレンジングジェル,クレンジングク
リーム等といった名称で販売されている洗浄料や洗顔料
がその代表的なものである。これらの皮膚洗浄料の使用
者は、これらを使用して洗い流した後や拭き取った後に
得られるさっぱりした感触を体感することや,視覚的に
メークが落ちたことを確認することで,これらの洗浄効
果を認識する傾向が強い。もちろん、適切な洗浄料を使
用することによって、実質的に十分な汚れ除去効果は得
られるのであるが、一方で「汚れを落とす」という化粧
行為をより積極的に楽しむための手段として、視覚的に
汚れが除去される過程を実感できる皮膚洗浄料が求めら
れている。BACKGROUND OF THE INVENTION Removing skin stains is the most fundamental step in skin care, and numerous forms of skin cleansers are on the market. Specifically, a cleaning agent and a face wash sold under the names of cleansing foam, cleansing gel, cleansing cream and the like are typical examples. Users of these skin cleansers should be able to feel the refreshing feel obtained after rinsing or wiping with them, or by visually confirming that makeup has fallen, There is a strong tendency to recognize the effect. Of course, by using an appropriate cleaning agent, a substantially sufficient stain removing effect can be obtained, but on the other hand, as a means of more positively enjoying the cosmetic act of "removing stains", visual There is a need for a skin cleanser that can realize the process of removing dirt.
【0003】視覚的に汚れが除去される過程を実感でき
る皮膚洗浄料としては、「皮膚に塗擦していくうちに肌
の上で汚れを含んだ垢状の凝集物が徐々に発生し,それ
を払い落としたり洗い流したりすることで皮膚を洗浄し
得る皮膚洗浄料」が理想とされてきた。そして、これを
具現化することを目的とした代表的な皮膚洗浄料が、ク
リーム等の乳化組成物に粉末を多く配合した剤型の皮膚
洗浄料である。この剤型の皮膚洗浄料は、皮膚上に塗布
して水分が揮散した後も肌上で擦り続けることにより,
粉末が油分(特に固形油分)と凝集して垢状になること
を利用したもので、油分や粉末の種類及び量の組合わせ
を工夫することによって、種々のタイプが得られる皮膚
洗浄料である。[0003] As a skin cleansing agent that can visually realize the process of removing dirt, a dirt-like aggregate containing dirt gradually forms on the skin as it is rubbed on the skin. A skin cleanser that can clean the skin by brushing off or rinsing has been considered ideal. A typical skin cleanser for realizing this is a skin cleanser in the form of a mixture of an emulsified composition such as a cream with a large amount of powder. The skin cleanser in this dosage form is applied on the skin and rubs on the skin even after the water evaporates,
It is a skin cleanser that uses various types of powders by using a combination of types and amounts of oils and powders. .
【0004】[0004]
【発明が解決しようとする課題】しかしながら、このク
リームタイプの皮膚洗浄料においては、いかに油分や粉
末の種類及び量の組合わせを工夫しても、最初は軽い
のびでも,凝集物が発生する時点でのびが重くなってし
まう;元来がクリーム状であるため,いかにもクリー
ムが固まって凝集したという感を免れず,皮膚の汚れも
同時に垢状に凝集されるような感覚に乏しい等の問題点
が付随する。However, in this cream type skin cleanser, no matter how the combination and type of the oil and powder are devised, even when the light weight is initially used, the point at which agglomerates are formed can be obtained. The problem is that the cream is inherently creamy, so the feeling that the cream hardens and agglomerates is inevitable, and the sensation that the dirt on the skin is also agglomerated at the same time is poor. Is accompanied.
【0005】そこで本発明が解決すべき課題は、皮膚に
塗擦した際に垢状の凝集物が発生する皮膚洗浄料におい
て、皮膚の汚れの除去効果に優れ,洗い流した後や拭き
取った後の皮膚状態が滑沢性にも優れると共に、汚れが
除去される過程がより視覚的に実感され得る皮膚洗浄料
を提供することにある。[0005] The problem to be solved by the present invention is to provide a skin cleansing agent which produces slime-like agglomerates when rubbed on the skin, has an excellent effect of removing skin stains, and has an effect of washing and wiping the skin. It is an object of the present invention to provide a skin cleansing agent which is excellent in lubricity and which allows the user to visually recognize the process of removing dirt.
【0006】[0006]
【課題を解決するための手段】本発明者は、この課題の
解決に向けて鋭意検討した結果、カルボキシビニルポリ
マーとモノアルキルトリメチルアンモニウム塩及び/又
はジアルキルジメチルアンモニウム塩を接触させること
で生じるハイドロゲルを系中に含む皮膚洗浄料は、皮膚
に塗擦した際に垢状の凝集物が発生し、皮膚の汚れの除
去効果にすぐれ,洗い流した後や拭き取った後の皮膚状
態が滑沢性にも優れることは勿論、その剤型が透明乃至
半透明であるため,垢状の凝集物の発生がクリームタイ
プのものと比較して劇的であり,汚れが除去される過程
を視覚的により実感できる皮膚洗浄料であることを見出
し、本発明を完成するに至った。Means for Solving the Problems As a result of intensive studies for solving the problems, the present inventors have found that hydrogels formed by contacting a carboxyvinyl polymer with a monoalkyltrimethylammonium salt and / or a dialkyldimethylammonium salt are obtained. The skin cleanser which contains in the system forms a scaly agglomerate when rubbed on the skin, has an excellent effect of removing dirt on the skin, and also has a lubricated skin condition after washing and wiping. Of course, since the dosage form is transparent or translucent, the generation of slime-like aggregates is more dramatic than that of the cream type, and the process of removing stains can be visually realized. The present inventors have found that it is a skin cleanser, and have completed the present invention.
【0007】すなわち、本発明者は以下の発明を本願に
おいて提供する。請求項1において、カルボキシビニル
ポリマー並びにモノアルキルトリメチルアンモニウム塩
及び/又はジアルキルジメチルアンモニウム塩を含んで
なる皮膚洗浄料を提供する。That is, the present inventor provides the following invention in the present application. Claim 1 provides a skin cleanser comprising a carboxyvinyl polymer and a monoalkyltrimethylammonium salt and / or a dialkyldimethylammonium salt.
【0008】請求項2において、前記請求項1記載の皮
膚洗浄料において、カルボキシビニルポリマー並びにモ
ノアルキルトリメチルアンモニウム塩及び/又はジアル
キルジメチルアンモニウム塩が接触して形成されるゲル
のpHが3以下である皮膚洗浄料を提供する。[0008] In the second aspect, the pH of the gel formed by contacting the carboxyvinyl polymer and the monoalkyltrimethylammonium salt and / or the dialkyldimethylammonium salt in the skin cleanser according to the first aspect is 3 or less. Provide a skin cleanser.
【0009】請求項3において、モノアルキルトリメチ
ルアンモニウム塩及び/又はジアルキルジメチルアンモ
ニウム塩を構成するアルキル基の炭素数が12以上22
以下である、前記請求項1又は請求項2記載の皮膚洗浄
料を提供する。In claim 3, the alkyl group constituting the monoalkyltrimethylammonium salt and / or the dialkyldimethylammonium salt has 12 to 22 carbon atoms.
The skin cleanser according to claim 1 or 2 is provided below.
【0010】請求項4において、前記請求項1乃至請求
項3のいずれかの請求項記載の皮膚洗浄料において、カ
ルボキシビニルポリマーの配合量が皮膚洗浄料の0.3
重量%以上,5.0重量%以下である皮膚洗浄料を提供
する。In the fourth aspect, the skin cleansing composition according to any one of the first to third aspects, wherein the content of the carboxyvinyl polymer is 0.3% of the skin cleansing composition.
Provided is a skin cleanser that is not less than 5.0 wt% and not more than 5.0 wt%.
【0011】請求項5において、前記請求項1乃至請求
項4のいずれかの請求項記載の皮膚洗浄料において、モ
ノアルキルトリメチルアンモニウム塩及び/又はジアル
キルジメチルアンモニウム塩の総配合量が皮膚洗浄料の
0.1重量%以上,3.0重量%以下である皮膚洗浄料
を提供する。[0011] In the fifth aspect, the total amount of the monoalkyltrimethylammonium salt and / or the dialkyldimethylammonium salt in the skin cleanser according to any one of the first to fourth aspects is less than that of the skin cleanser. Provided is a skin cleanser that is 0.1% by weight or more and 3.0% by weight or less.
【0012】[0012]
【発明の実施の形態】以下、本発明の実施の形態につい
て説明する。本発明皮膚洗浄料は、アニオン性の水溶性
高分子であるカルボキシビニルポリマー並びにカチオン
であるモノアルキルトリメチルアンモニウム塩及び/又
はジアルキルジメチルアンモニウム塩が接触することに
より形成されるハイドロゲルが,皮膚洗浄料の配合要素
として皮膚上で塗擦される間に徐々に垢状の凝集物を形
成することを利用して、所期の効果を達成する皮膚洗浄
料である。Embodiments of the present invention will be described below. The skin cleansing composition of the present invention comprises a carboxyvinyl polymer as an anionic water-soluble polymer and a hydrogel formed by contact with a cation, a monoalkyltrimethylammonium salt and / or a dialkyldimethylammonium salt. It is a skin cleanser that achieves the desired effect by utilizing the formation of slime-like aggregates gradually while being rubbed on the skin.
【0013】上記ハイドロゲル形成に関わるアニオン性
の水溶性高分子であるカルボキシビニルポリマーは、主
にアクリル酸が重合してなる酸性高分子化合物であり、
その重合度や架橋度の違いにより種々のグレードが市販
されているが、本発明に用いるカルボキシビニルポリマ
ーは、いずれのタイプでも可能である。The carboxyvinyl polymer, which is an anionic water-soluble polymer involved in the formation of the hydrogel, is an acidic polymer compound mainly formed by polymerization of acrylic acid.
Various grades are commercially available depending on the degree of polymerization and the degree of crosslinking, and any type of carboxyvinyl polymer used in the present invention is possible.
【0014】具体的には、BFGoodrich社製のカーボポー
ル(Carbopol)シリーズ;住友精化社製のAqupecHVシリー
ズ;日本純薬社製のジュンロンPWシリーズ;和光純薬
社製のハイビスワコーシリーズ等の各市販品を本発明皮
膚洗浄料において配合することが可能である。[0014] Specifically, BFGoodrich's Carbopol series; Sumitomo Seika's AqupecHV series; Nippon Pure Chemicals 'Junron PW series; Wako Pure Chemicals' Hibiswako series, etc. Commercial products can be incorporated in the skin cleanser of the present invention.
【0015】なお、他の静電的態様の水溶性高分子の一
態様であるノニオン性の水溶性高分子、例えばメチルセ
ルロースやヒドロキシプロピルセルロースを上記カチオ
ンと接触させて皮膚洗浄料に配合しても垢状の凝集物が
発生せず好ましくない。また、他の態様であるアニオン
性の水溶性高分子、例えばキサンタンガムやカルボキシ
メチルセルロースを上記カチオンと接触させても安定な
ハイドロゲルが形成されず好ましくない。A nonionic water-soluble polymer, which is an embodiment of another water-soluble polymer in an electrostatic form, such as methylcellulose or hydroxypropylcellulose, may be brought into contact with the above-mentioned cation and blended into a skin cleanser. It is not preferable because no scaly aggregates are generated. Further, even when an anionic water-soluble polymer, such as xanthan gum or carboxymethyl cellulose, which is another embodiment, is brought into contact with the above-mentioned cation, a stable hydrogel is not formed, which is not preferable.
【0016】ただし、後述するようにこれらの他の静電
的態様の高分子をはじめ、カルボキシビニルポリマー以
外の水溶性高分子も、必要に応じて本発明洗浄用組成物
に補助的な成分として配合されることは妨げられるもの
ではない。However, as described later, water-soluble polymers other than the carboxyvinyl polymer, as well as these other electrostatic polymers, may be used as auxiliary components in the cleaning composition of the present invention, if necessary. The compounding is not prevented.
【0017】このカルボキシビニルポリマーと上記アニ
オンとを接触させて形成させるハイドロゲルのpHは3
以下であることが好ましい。pHが3を超える領域で
は、カルボキシビニルポリマーと上記カチオンとが、静
電気的相互作用による複合体を形成し、この複合体同士
の凝集が系中に生成して安定なハイドロゲルが得られな
くなる傾向が強くなり好ましくない。The pH of the hydrogel formed by contacting the carboxyvinyl polymer with the anion is 3
The following is preferred. In the region where the pH exceeds 3, the carboxyvinyl polymer and the cation form a complex due to electrostatic interaction, and aggregation of the complex is formed in the system, so that a stable hydrogel tends not to be obtained. Becomes strong, which is not preferable.
【0018】この意味では、本発明において用いられる
カルボキシビニルポリマーは系に未中和の状態(酸性)
で配合することが好ましい。例えばカルボキシビニルポ
リマーカルシウム・カリウム塩等を系に配合すると、他
にpH調製剤等を添加しない限り上記のごとく複合体が
系において形成されることになり好ましくない。In this sense, the carboxyvinyl polymer used in the present invention is in an unneutralized (acidic) state in the system.
It is preferable to mix them. For example, if a carboxyvinyl polymer calcium / potassium salt is added to the system, a complex is formed in the system as described above unless a pH adjuster or the like is added, which is not preferable.
【0019】本発明皮膚洗浄料におけるカルボキシビニ
ルポリマーの配合量は、皮膚洗浄料の0.3重量%以
上,5.0重量%以下であることが好ましい。The compounding amount of the carboxyvinyl polymer in the skin cleanser of the present invention is preferably from 0.3% by weight to 5.0% by weight of the skin cleanser.
【0020】この配合量が皮膚洗浄料の0.3重量%未
満であると,十分な粘度のゲルが形成されず好ましくな
く、同5.0重量%を超えて配合すると,形成されるハ
イドロゲルの粘度が高すぎて,かえって本発明皮膚洗浄
料の使用感が損なわれることになり好ましくない。If the amount is less than 0.3% by weight of the skin cleansing agent, a gel having a sufficient viscosity is not formed, which is not preferable. If the amount is more than 5.0% by weight, a hydrogel is formed. Is too high, which undesirably impairs the feeling of use of the skin cleanser of the present invention.
【0021】本発明皮膚洗浄料においては、このカルボ
キシビニルポリマーに,カチオンとしてモノアルキルト
リメチルアンモニウム塩及び/又はジアルキルジメチル
アンモニウム塩を接触させることにより、系中でハイド
ロゲルが形成される。In the skin cleanser of the present invention, a hydrogel is formed in the system by bringing a monoalkyltrimethylammonium salt and / or a dialkyldimethylammonium salt into contact with the carboxyvinyl polymer as a cation.
【0022】このモノアルキルトリメチルアンモニウム
塩及び/又はジアルキルジメチルアンモニウム塩の塩と
しての形態は、水や水/アルコール混合系に溶解する形
態であればよく、塩化物や臭化物などのハロゲン化物と
しての形態が一般的である。カルシウムイオンやマグネ
シウムイオン等の金属イオンのカチオンとしての形態を
とる場合には、上記のカルボキシビニルポリマーと接触
させても,安定なハイドロゲル組成物が得られず好まし
くない。The monoalkyltrimethylammonium salt and / or dialkyldimethylammonium salt may be in any form as long as it can be dissolved in water or a water / alcohol mixture, and may be in the form of a halide such as chloride or bromide. Is common. When a metal ion such as a calcium ion or a magnesium ion is in the form of a cation, it is not preferable because a stable hydrogel composition cannot be obtained even when the metal ion is brought into contact with the carboxyvinyl polymer.
【0023】また、このモノアルキルトリメチルアンモ
ニウム塩及び/又はジアルキルジメチルアンモニウム塩
を構成するアルキル基の炭素数は、12以上22以下で
あることが好ましい。この炭素数が12未満の場合,こ
れを用いてなる本発明皮膚洗浄料を皮膚に塗擦した際に
発生する垢状の凝集物が明確でなくなる傾向があり、同
炭素数が22を超える場合,カルボキシビニルポリマー
と接触させて得られるハイドロゲルの安定性が低下する
傾向にある。The alkyl group constituting the monoalkyltrimethylammonium salt and / or the dialkyldimethylammonium salt preferably has 12 to 22 carbon atoms. When the number of carbon atoms is less than 12, the scale-like aggregates generated when the skin cleansing agent of the present invention is rubbed on the skin tend to be unclear, and when the number of carbon atoms is more than 22, Hydrogels obtained by contact with a carboxyvinyl polymer tend to have reduced stability.
【0024】上記のモノアルキルトリメチルアンモニウ
ム塩及び/又はジアルキルジメチルアンモニウム塩は、
通常公知の方法を用いて製造したものを本発明皮膚洗浄
料において用いることも、市販品を用いることも可能で
ある。The above monoalkyltrimethylammonium salt and / or dialkyldimethylammonium salt is
What was manufactured using a publicly known method can be used for the skin cleansing agent of the present invention, or a commercial product can be used.
【0025】本発明皮膚洗浄料におけるモノアルキルト
リメチルアンモニウム塩および/またはジアルキルジメ
チルアンモニウム塩の総配合量は、皮膚洗浄料の0.1
重量%以上,3.0%重量%以下であることが好まし
い。この総配合量が皮膚洗浄料の0.1重量%未満の場
合、本発明皮膚洗浄料を皮膚に塗擦した際に発生する垢
状の凝集物が明確でなくなる傾向があり、同3.0重量
%を超えて配合しても配合量に増加に見合った凝集物発
生の増加は認められない。The total amount of the monoalkyltrimethylammonium salt and / or the dialkyldimethylammonium salt in the skin cleanser of the present invention is 0.1% of the skin cleanser.
It is preferable that the content is not less than 3.0% by weight and not more than 3.0% by weight. If the total amount is less than 0.1% by weight of the skin cleanser, the scale-like aggregates generated when the skin cleanser of the present invention is rubbed on the skin tend not to be clear, and the total weight is 3.0%. %, There is no increase in the generation of aggregates commensurate with the increase in the amount.
【0026】本発明の皮膚洗浄料には、上記構成成分の
他に必要に応じ、一般的に化粧料に配合される各種成分
を本発明の所期の効果を妨げない限り配合することがで
きる。例えば、本発明皮膚洗浄料は、皮膚洗浄料として
採り得る各種の剤型及び形態、例えば透明乃至半透明ジ
ェル,ジェル状クリーム等の剤形を採ることが可能であ
り、これらの具体的剤型や形態に応じた基剤成分を配合
することが可能であり、本発明皮膚洗浄料に何らかの薬
効を付与する場合には、その薬効に応じた薬効成分を本
発明皮膚洗浄料中に配合することができる。In the skin cleanser of the present invention, in addition to the above-mentioned constituents, if necessary, various components generally incorporated in cosmetics can be incorporated as long as the desired effects of the present invention are not hindered. . For example, the skin cleanser of the present invention can take various forms and forms that can be used as the skin cleanser, such as transparent to translucent gels and gel creams. It is possible to mix a base component according to the form and form, and when imparting any medicinal effect to the skin cleansing agent of the present invention, compounding a medicinal component according to the medicinal effect in the skin cleansing agent of the present invention. Can be.
【0027】これらの成分としては、例えば油性成分,
界面活性剤,保湿剤,高級アルコール,金属イオン封鎖
剤,天然および合成高分子,水溶性および油溶性高分
子,紫外線吸収剤,血行促進剤,各種抽出液,無機およ
び有機顔料,無機および有機粘土鉱物,金属石鹸処理ま
たはシリコーンで処理された無機および有機顔料,有機
染料等の色剤,防腐剤,酸化防止剤,色素,増粘剤,p
H調整剤,香料,清涼剤,制汗剤,殺菌剤,皮膚賦活剤
等が挙げられる。As these components, for example, oily components,
Surfactants, moisturizers, higher alcohols, sequestering agents, natural and synthetic polymers, water-soluble and oil-soluble polymers, ultraviolet absorbers, blood circulation enhancers, various extracts, inorganic and organic pigments, inorganic and organic clays Coloring agents such as inorganic and organic pigments and organic dyes treated with minerals, metallic soaps or silicones, preservatives, antioxidants, pigments, thickeners, p
H regulators, fragrances, cooling agents, antiperspirants, bactericides, skin activators, and the like.
【0028】油分としては、例えばアボガド油,ツバキ
油,タートル油,マカデミアナッツ油,トウモロコシ
油,ミンク油,オリーブ油,ナタネ油,卵黄油,ゴマ
油,パーシック油,小麦胚芽油,サザンカ油,ヒマシ
油,アマニ油,サフラワー油,綿実油,エノ油,大豆
油,落花生油,茶実油,カヤ油,コメヌカ油,シナギリ
油,日本キリ油,ホホバ油,胚芽油,トリグリセリン,
トリオクタン酸グリセリン,トリイソパルミチン酸グリ
セリン,カカオ脂,ヤシ油,馬脂,硬化ヤシ油,パーム
油,牛脂,羊脂,硬化牛脂,パーム核油,豚脂,牛骨
脂,モクロウ核油,硬化油,牛脚脂,モクロウ,硬化ヒ
マシ油,ミツロウ,カンデリラロウ,綿ロウ,カルナウ
バロウ,ベイベリーロウ,イボタロウ,鯨ロウ,モンタ
ンロウ,ヌカロウ,ラノリン,カポックロウ,酢酸ラノ
リン,液状ラノリン,サトウキビロウ,ラノリン脂肪酸
イソプロピル,ラウリン酸ヘキシル,還元ラノリン,ジ
ョジョバロウ,硬質ラノリン,セラックロウ, POEラノ
リンアルコールエーテル, POEラノリンアルコールアセ
テート, POEコレステロールエーテル,ラノリン脂肪酸
ポリエチレングリコール, POE水素添加ラノリンアルコ
ールエーテル,流動パラフィン,オゾケライト,スクワ
レン,プリスタン,パラフィン,セレシン,スクワレ
ン,ワセリン,マイクロクリスタリンワックス等が挙げ
られる。Examples of the oil component include avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, southern oil, castor oil, linseed oil Oil, safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, teaseed oil, kaya oil, rice bran oil, sinagiri oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin,
Glycerin trioctanoate, glycerin triisopalmitate, cocoa butter, coconut oil, horse fat, hydrogenated coconut oil, palm oil, beef tallow, sheep tallow, hydrogenated tallow, palm kernel oil, lard, beef tallow, mokuro kernel oil, hydrogenated Oil, beef tallow, mokuro, hardened castor oil, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, whale wax, montan wax, nukarou, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, isopropyl lanolin fatty acid, laurin Hexyl acid, reduced lanolin, jojoba wax, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, liquid paraffin Quinone, ozokerite, squalene, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax and the like.
【0029】親油性非イオン界面活性剤としては、例え
ばソルビタンモノオレエート,ソルビタンモノイソステ
アレート,ソルビタンモノラウレート,ソルビタンモノ
パルミテート,ソルビタンモノステアレート,ソルビタ
ンセスキオレエート,ソルビタントリオレエート,ペン
タ-2- エチルヘキシル酸ジグリセロールソルビタン,テ
トラ-2- エチルヘキシル酸ジグリセロールソルビタン等
のソルビタン脂肪酸エステル類;モノ綿実油脂肪酸グリ
セリン,モノエルカ酸グリセリン,セスキオレイン酸グ
リセリン,モノステアリン酸グリセリン、α, α'-オレ
イン酸ピログルタミン酸グリセリン,モノステアリン酸
グリセリンリンゴ酸等のグリセリンポリグリセリン脂肪
酸類;モノステアリン酸プロピレングリコール等のプロ
ピレングリコール脂肪酸エステル類;硬化ヒマシ油誘導
体,グリセリンアルキルエーテル等が挙げられる。Examples of the lipophilic nonionic surfactant include sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate, and pentane Sorbitan fatty acid esters such as diglycerol sorbitan-2-ethylhexylate and diglycerol sorbitan tetra-2-ethylhexylate; glycerin mono-cottonseed oil fatty acid, glycerin monoerucate, glycerin sesquioleate, glyceryl monostearate, α, α'-olein Polyglycerin fatty acids such as glyceryl pyroglutamate and glyceryl monostearate; propylene glycol fatty acids such as propylene glycol monostearate Esters: hydrogenated castor oil derivatives, glycerin alkyl ethers and the like.
【0030】親水性非イオン界面活性剤としては、例え
ば POEソルビタンモノオレエート,POE-ソルビタンモノ
ステアレート,POE-ソルビタンモノオレート,POE-ソル
ビタンテトラオレエート等の POEソルビタン脂肪酸エス
テル類;POE-ソルビットモノラウレート,POE-ソルビッ
トモノオレエート,POE-ソルビットペンタオレエート,
POE-ソルビットモノステアレート等の POEソルビット脂
肪酸エステル類;POE-グリセリンモノステアレート,PO
E-グリセリンモノイソステアレート,POE-グリセリント
リイソステアレート等の POEグリセリン脂肪酸エステル
類;POE モノオレエート,POE ジステアレート,POE モ
ノジオレエート,システアリン酸エチレングリコール等
のPOE 脂肪酸エステル類;POE ラウリルエーテル,POE
オレイルエーテル,POE ステアリルエーテル,POE ベヘ
ニルエーテル,POE2- オクチルドデシルエーテル,POE
コレスタノールエーテル等のPOE アルキルエーテル類;
POE オクチルフェニルエーテル,POE ノニルフェニルエ
ーテル,POE ジノニルフェニルエーテル等のPOE アルキ
ルフェニルエーテル類;ブルロニック等のプルアロニッ
ク型類; POE・POPセチルエーテル, POE・POP2 -デシ
ルテトラデシルエーテル, POE・POP モノブチルエーテ
ル, POE・POP 水添ラノリン, POE・POP グリセリンエ
ーテル等の POE・POP アルキルエーテル類;テトロニッ
ク等のテトラPOE・テトラ POPエチレンジアミン縮合物
類; POEヒマシ油, POE硬化ヒマシ油, POE硬化ヒマシ
油モノイソステアレート, POE硬化ヒマシ油トリイソス
テアレート, POE硬化ヒマシ油モノピログルタミン酸モ
ノイソステアリン酸ジエステル,POE 硬化ヒマシ油マレ
イン酸等のPOE ヒマシ油硬化ヒマシ油誘導体;POE ソル
ビットミツロウ等のPOE ミツロウ・ラノリン誘導体;ヤ
シ油脂肪酸ジエタノールアミド,ラウリン酸モノエタノ
ールアミド,脂肪酸イソプロパノールアミド等のアルカ
ノールアミド;POE プロピレングリコール脂肪酸エステ
ル,POE アルキルアミン,POE 脂肪酸アミド,ショ糖脂
肪酸エステル,POE ノニルフェニルホルムアルデヒド縮
合物,アルキルエトキシジメチルアミンオキシド,トリ
オレイルリン酸等が挙げられる。Examples of the hydrophilic nonionic surfactant include POE sorbitan fatty acid esters such as POE sorbitan monooleate, POE-sorbitan monostearate, POE-sorbitan monooleate, POE-sorbitan tetraoleate; and POE-sorbit. Monolaurate, POE-Sorbit monooleate, POE-Sorbit pentaoleate,
POE sorbite fatty acid esters such as POE-sorbitol monostearate; POE-glycerin monostearate, PO
POE glycerin fatty acid esters such as E-glycerin monoisostearate and POE-glycerin triisostearate; POE fatty acid esters such as POE monooleate, POE distearate, POE monodioleate, ethylene glycol cysteate; POE lauryl ether, POE
Oleyl ether, POE stearyl ether, POE behenyl ether, POE2-octyldodecyl ether, POE
POE alkyl ethers such as cholestanol ether;
POE Alkyl phenyl ethers such as POE octyl phenyl ether, POE nonyl phenyl ether, POE dinonyl phenyl ether; Pluronics such as bruronic; POE / POP cetyl ether, POE / POP2-decyltetradecyl ether, POE / POP monobutyl ether , POE / POP hydrogenated lanolin, POE / POP alkyl ethers such as glycerin ether; Tetronic, etc., tetra-POE / tetra-POP ethylenediamine condensates; POE castor oil, POE hardened castor oil, POE hardened castor oil mono POE castor oil derivatives such as isostearate, POE hydrogenated castor oil triisostearate, POE cured castor oil monopyroglutamic acid monoisostearate diester, POE hydrogenated castor oil maleic acid; POE beeswax lanolin such as POE sorbitol beeswax Derivative; palm Alkanolamides such as fatty acid diethanolamide, lauric acid monoethanolamide, and fatty acid isopropanolamide; POE propylene glycol fatty acid ester, POE alkylamine, POE fatty acid amide, sucrose fatty acid ester, POE nonylphenylformaldehyde condensate, alkylethoxydimethylamine oxide, And trioleyl phosphoric acid.
【0031】アニオン界面活性剤としては,例えばセッ
ケン用素地,ラウリン酸ナトリウム,パルミチン酸ナト
リウム等の脂肪酸セッケン;ラウリル硫酸ナトリウム,
ラウリル硫酸K 等の高級アルキル硫酸エステル塩;POE
ラウリル硫酸トリエタノールアミン,POE ラウリル硫酸
ナトリウム等のアルキルエーテル硫酸エステル塩;ラウ
ロイルサルコシンナトリウム等のN-アシルサルコシン
酸;N-ミリストイル-N-メチルタウリンナトリウム,ヤ
シ油脂肪酸メチルタウリッドナトリウム,ラウリルメチ
ルタウリッドナトリウム等の高級脂肪酸アミドスルホン
酸塩;POE オレイルエーテルリン酸ナトリウム,POE ス
テアリルエーテルリン酸等のリン酸エステル塩;ジ-2-
エチルヘキシルスルホコハク酸ナトリウム,モノラウロ
イルモノエタノールアミドポリオキシエチレンスルホコ
ハク酸ナトリウム,ラウリルポリプロピレングリコール
スルホコハク酸ナトリウム等のスルホコハク酸塩:リニ
アドデシルベンゼンスルホン酸ナトリウム,リニアドデ
シルベンゼンスルホン酸トリエタノールアミン,リニア
ドデシルベンゼンスルホン酸等のアルキルベンゼンスル
ホン酸塩;N-ラウロイルグルタミン酸モノナトリウム,
N-ステアロイルグルタミン酸ジナトリウム,N-ミリスト
イル-L- グルタミン酸モノナトリウム等のN-アシルグル
タミン酸塩;硬化ヤシ油脂肪酸グリセリン硫酸ナトリウ
ム等の高級脂肪酸エステル硫酸エステル塩;ロート油等
の硫酸化油;POE アルキルエーテルカルボン酸,POE ア
ルキルアリルエーテルカルボン酸塩,α- オレフィンス
ルホン酸塩,高級脂肪酸エステルスルホン酸塩,二級ア
ルコール硫酸エステル塩,高級脂肪酸アルキロールアミ
ド硫酸エステル塩,ラウロイルモノエタノールアミドコ
ハク酸ナトリウム,N-パルミトイルアスパラギン酸ジト
リエタノールアミン,カゼインナトリウム等が挙げられ
る。Examples of the anionic surfactant include a soap base, a fatty acid soap such as sodium laurate and sodium palmitate; sodium lauryl sulfate;
Higher alkyl sulfates such as lauryl sulfate K; POE
Alkyl ether sulfates such as triethanolamine lauryl sulfate and POE sodium lauryl sulfate; N-acyl sarcosine acids such as sodium lauroyl sarcosine; N-myristoyl-N-methyl taurine sodium; coconut oil fatty acid methyl tauride sodium; lauryl methyl tau Higher fatty acid amide sulfonates such as sodium lid; phosphate ester salts such as sodium POE oleyl ether phosphate and POE stearyl ether phosphate; di-2-
Sulfosuccinates such as sodium ethylhexylsulfosuccinate, monolauroylmonoethanolamide sodium polyoxyethylene sulfosuccinate, sodium lauryl polypropylene glycol sodium sulfosuccinate: sodium linear dodecylbenzenesulfonate, triethanolamine linear dodecylbenzenesulfonate, lineardodecylbenzenesulfonate Alkylbenzenesulfonates such as monosodium N-lauroylglutamate;
N-acyl glutamates such as disodium N-stearoylglutamate and monosodium N-myristoyl-L-glutamate; higher fatty acid ester sulfates such as hydrogenated coconut oil fatty acid sodium glycerin sulfate; sulfated oils such as funnel oil; POE alkyl Ether carboxylic acid, POE alkyl allyl ether carboxylate, α-olefin sulfonate, higher fatty acid ester sulfonate, secondary alcohol sulfate, higher fatty acid alkylolamide sulfate, sodium lauroyl monoethanolamidosuccinate, N-palmitoyl aspartate ditriethanolamine, sodium caseinate and the like.
【0032】カチオン界面活性剤としては、例えば塩化
ポリ(N,N'-ジメチル-3,5- メチレンピペリジニウム),塩
化セチルピリジニウム等のアルキルピリジニウム塩;ア
ルキル四級アンモニウム塩,アルキルジメチルベンジル
アンモニウム塩,アルキルイソキノリニウム塩,ジアル
キルモリホニウム塩,POE アルキルアミン,アルキルア
ミン塩,ポリアミン脂肪酸誘導体,アミルアルコール脂
肪酸誘導体,塩化ベンザルコニウム,塩化ベンゼトニウ
ム等が挙げられる。Examples of the cationic surfactant include alkylpyridinium salts such as poly (N, N'-dimethyl-3,5-methylenepiperidinium chloride) and cetylpyridinium chloride; alkyl quaternary ammonium salts; alkyldimethylbenzylammonium Salts, alkyl isoquinolinium salts, dialkyl morphonium salts, POE alkylamines, alkylamine salts, polyamine fatty acid derivatives, amyl alcohol fatty acid derivatives, benzalkonium chloride, benzethonium chloride and the like.
【0033】両性界面活性剤としては、例えば2-ウンデ
シル-N,N,N-(ヒドロキシエチルカルボキシメチル)-2-イ
ミダゾリンナトリウム,2-ココイル−2−イミタゾリニ
ウムヒドロキサイド-1- カルボキシエチロキシ2 ナトリ
ウム塩等のイミダゾリン系両性界面活性剤;2-ヘプタデ
シル-N- カルボキシメチル-N- ヒドロキシエチルイミダ
ゾリニウムベタイン,ラウリルジメチルアミノ酢酸ベタ
イン,アルキルベタイン,アミドベタイン,スルホベタ
イン等のベタイン系界面活性剤等が挙げられる。Examples of the amphoteric surfactant include 2-undecyl-N, N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium and 2-cocoyl-2-imitazolinium hydroxide-1-carboxyethyl. Imidazoline-based amphoteric surfactants such as roxy disodium salt; betaine-based interfaces such as 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetate betaine, alkylbetaine, amidobetaine, and sulfobetaine Activators and the like.
【0034】保湿剤としては、例えばポリエチレングリ
コール,プロピレングリコール,グルセリン、1,3-ブチ
レングリコール,キシリトール,ソルビトール,マルチ
トール,コンドロイチン硫酸,ヒアルロン酸,ムコイチ
ン硫酸,カロニン酸,アテロコラーゲン,コレステリル
-12-ヒドロキシステアレート,乳酸ナトリウム,胆汁酸
塩,dl- ピロリドンカルボン酸塩,短鎖可溶性コラーゲ
ン,ジグリセリン(EO)PO付加物,イザヨイバラ抽出物,
セイヨウノコギリソウ抽出物,メリロート抽出物等が挙
げられる。Examples of the humectant include polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronic acid, atelocollagen, cholesteryl.
-12-hydroxystearate, sodium lactate, bile salts, dl-pyrrolidone carboxylate, short-chain soluble collagen, diglycerin (EO) PO adduct, Izayobara extract,
An extract of Achillea millefolium, an extract of melilot and the like.
【0035】高級アルコールとしては、例えばラウリル
アルコール,セチルアルコール,ステアリルアルコー
ル,ベヘニルアルコール,ミリスチルアルコール,オレ
イルアルコール,セトステアリルアルコール等の直鎖ア
ルコール;モノステアリルグリセリンエーテル(バチル
アルコール),2-デシルテトラデシノール,ラノリンア
ルコール,コレステロール,フィトステロール,ヘキシ
ルドデカノール,イソステアリルアルコール,オクチル
ドデカノール等の分枝鎖アルコール等があげられる。The higher alcohols include, for example, linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol; monostearyl glycerin ether (bacyl alcohol), 2-decyltetradecinol Lanolin alcohol, cholesterol, phytosterol, hexyl decanol, isostearyl alcohol, octyl dodecanol and the like, and branched alcohols.
【0036】金属イオン封鎖剤としては,例えば1-ヒド
ロキシエタン-1,1- ジフォスホン酸,1-ヒドロキシエタ
ン-1,1- ジフォスホン酸四ナトリウム塩,エデト酸二ナ
トリウム,エデト酸三ナトリウム,エデト酸四ナトリウ
ム,クエン酸ナトリウム,ポリリン酸ナトリウム,メタ
リン酸ナトリウム,グルコン酸,リン酸,クエン酸,ア
スコルビン酸,コハク酸,エデト酸等が挙げられる。Examples of sequestering agents include 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, edetate disodium, edetate trisodium, edetate Examples thereof include tetrasodium, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, and edetic acid.
【0037】天然の水溶性高分子としては、例えばアラ
アビアガム,トラガカントガム,ガラクタン,グアガ
ム,キャロブガム,カラヤガム,カラギーナン,ペクチ
ン,カンテン,クインスシード(マルメロ),アルゲコ
ロイド(カッソウエキス),デンプン(コメ,トウモロ
コシ,バレイショ,コムギ),グリチルリチン酸等の植
物系高分子;キサンタンガム,デキストラン,サクシノ
グルカン,プルラン等の微生物系高分子;コラーゲン,
カゼイン,アルブミン,ゼラチン等の動物系高分子が挙
げられる。Examples of natural water-soluble polymers include, for example, arabia gum, tragacanth gum, galactan, guar gum, carob gum, karaya gum, carrageenan, pectin, agar, quince seed (quince), alge colloid (cassow extract), starch (rice, corn, potato). , Wheat), glycyrrhizic acid, etc .; plant macromolecules; xanthan gum, dextran, succinoglucan, pullulan, etc .;
Animal-based polymers such as casein, albumin, and gelatin are exemplified.
【0038】半合成の水溶性高分子としては、例えばカ
ルボキシメチルデンプン,メチルヒドロキシプロピルデ
ンプン等のデンプン系高分子;メチルセルロース,ニト
ロセルロース,エチルセルロース,メチルヒドロキシプ
ロピルセルロース,ヒドロキシエチルセルロース,セル
ロース硫酸ナトリウム,ヒドロキシプロピルセルロー
ス,カルボキシメチルセルロースナトリウム(CMC),結
晶セルロース,セルロース末等のセルロース系高分子;
アルギン酸ナトリウム,アルギン酸プロピレングリコー
ルエステル等のアルギン酸系高分子が挙げられる。Examples of the semi-synthetic water-soluble polymer include starch-based polymers such as carboxymethyl starch and methyl hydroxypropyl starch; methyl cellulose, nitrocellulose, ethyl cellulose, methyl hydroxypropyl cellulose, hydroxyethyl cellulose, cellulose sodium sulfate, and hydroxypropyl. Cellulose-based polymers such as cellulose, sodium carboxymethylcellulose (CMC), crystalline cellulose, and cellulose powder;
Alginic acid polymers such as sodium alginate and propylene glycol alginate are exemplified.
【0039】合成の水溶性高分子としては、例えばポリ
ビニルアルコール,ポリビニルメチルエーテル,ポリビ
ニルピロリドン等のビニル系高分子;ポリエチレングリ
コール20,000、4,000,000 、600,000 等のポリオキシエ
チレン系高分子;ポリオキシエチレンポリオキシプロピ
レン共重合体共重合系高分子;ポリアクリル酸ナトリウ
ム,ポリエチルアクリレート,ポリアクリルアミド等の
アクリル系高分子;ポリエチレンイミン,カチオンポリ
マー等が挙げられる。Examples of the synthetic water-soluble polymer include vinyl polymers such as polyvinyl alcohol, polyvinyl methyl ether and polyvinyl pyrrolidone; polyoxyethylene polymers such as polyethylene glycol 20,000, 4,000,000 and 600,000; polyoxyethylene polyoxy. Propylene copolymer copolymer-based polymers; acrylic polymers such as sodium polyacrylate, polyethyl acrylate, and polyacrylamide; polyethylene imine, cationic polymers, and the like.
【0040】無機の水溶性高分子としては、例えばベン
トナイト,ケイ酸A1Mg( ビーガム),ラポナイト,ヘク
トライト,無水ケイ酸等が挙げられる。Examples of the inorganic water-soluble polymer include bentonite, silicic acid A1Mg (beegum), laponite, hectorite, silicic anhydride and the like.
【0041】紫外線吸収剤としては、例えばパラアミノ
安息香酸 (以下 PABA と略す) 、PABAモノグリセリンエ
ステル、N,N-ジプロポキシPABAエチルエステル、N,N-ジ
エトキシPABAエチルエステル、N,N-ジメチルPABAエチル
エステル、N,N-ジメチルPABAブチルエステル等のパラア
ミノ安息香酸系紫外線吸収剤;ホモメンチル-N- アセチ
ルアントラニレート等のアントラニル酸系紫外線吸収
剤;アミルサリシレート、メンチルサリシレート、ホモ
メンチルサリシレート、オクチルサリシレート、フェニ
ルサリシレート、ベンジルサリシレート、p-イソプロパ
ノールフェニルサリシレート等のサリチル酸系紫外線吸
収剤;オクチルシンナメート、エチル-4-イソプロピル
シンナメート、メチル-2,5- ジイソプロピルシンナメー
ト、エチル-2,4- ジイソプロピルシンナメート、メチル
-2,4- ジイソプロピルシンナメート、プロピル-p- メト
キシシンナメート、イソプロピル-p- メトキシシンナメ
ート、イソアミル-p- メトキシシンナメート、オクチル
-p- メトキシシンナメート(2- エチルヘキシル-p- メト
キシシンナメート) 、2-エトキシエチル-p- メトキシシ
ンナメート、シクロヘキシル-p- メトキシシンナメー
ト、エチル- α- シアノ−β- フェニルシンナメート、
2-エチルヘキシル- α- シアノ- β- フェニルシンナメ
ート、グリセリルモノ-2- エチルヘキサノイル- ジパラ
メトキシシンナメート等の桂皮酸系紫外線吸収剤;2,4-
ジヒドロキシベンゾフェノン、2,2'- ジヒドロキシ-4-
メトキシベンゾフェノン、2,2'- ジヒドロキシ-4,4'-ジ
メトキシベンゾフェノン、2,2',4,4'-テトラヒドロキシ
ベンゾフェノン、2-ヒドロキシ-4-メトキシベンゾフェ
ノン、2-ヒドロキシ-4- メトキシ-4'-メチルベンゾフェ
ノン、2-ヒドロキシ-4- メトキシベンゾフェノン-5- ス
ルホン酸塩、4-フェニルベンゾフェノン、2-エチルヘキ
シル-4'-フェニル- ベンゾフェノン-2- カルボキシレー
ト、2-ヒドロキシ-4-n- オクトキシベンゾフェノン、4-
ヒドロキシ-3- カルボキシベンゾフェノン等のベンゾフ
ェノン系紫外線吸収剤;3-(4'-メチルベンジリデン)-
d,1- カンファー、3-ベンジリデン-d,1- カンファー、
ウロカニン酸、ウロカニン酸エチルエステル、2-フェニ
ル-5- メチルベンゾキサゾール、2,2'- ヒドロキシ-5-
メチルフェニルベンゾトリアゾール、2-(2'-ヒドロキシ
-5'-t-オクチルフェニル) ベンゾトリアゾール、2-(2'-
ヒドロキシ-5'-メチルフェニルベンゾトリアゾール、ジ
ベンザラジン、ジアニソイルメタン、4-メトキシ-4'-t-
ブチルジベンゾイルメタン、5-(3,3- ジメチル-2- ノル
ボルニリデン)-3-ペンタン-2- オン等が挙げられる。Examples of the ultraviolet absorber include paraaminobenzoic acid (hereinafter abbreviated as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester, N, N-dimethyl PABA ethyl Esters, N, N-dimethyl PABA butyl ester and other paraaminobenzoic acid-based ultraviolet absorbers; homomenthyl-N-acetylanthranilate and other anthranilic acid-based ultraviolet absorbers; amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate, Salicylic acid ultraviolet absorbers such as phenyl salicylate, benzyl salicylate, and p-isopropanol phenyl salicylate; octylcinnamate, ethyl-4-isopropylcinnamate, methyl-2,5-diisopropylcinnamate, ethyl-2,4-diisopropylcinnamate , Methyl
-2,4-Diisopropylcinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, octyl
-p-methoxycinnamate (2-ethylhexyl-p-methoxycinnamate), 2-ethoxyethyl-p-methoxycinnamate, cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate,
Cinnamic acid ultraviolet absorbers such as 2-ethylhexyl-α-cyano-β-phenylcinnamate and glyceryl mono-2-ethylhexanoyl-diparamethoxycinnamate; 2,4-
Dihydroxybenzophenone, 2,2'-dihydroxy-4-
Methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4 '-Methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4-phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octo Xybenzophenone, 4-
Benzophenone UV absorbers such as hydroxy-3-carboxybenzophenone; 3- (4'-methylbenzylidene)-
d, 1-camphor, 3-benzylidene-d, 1-camphor,
Urocanic acid, urocanic acid ethyl ester, 2-phenyl-5-methylbenzoxazole, 2,2'-hydroxy-5-
Methylphenylbenzotriazole, 2- (2'-hydroxy
-5'-t-octylphenyl) benzotriazole, 2- (2'-
Hydroxy-5'-methylphenylbenzotriazole, dibenzarazine, dianisoylmethane, 4-methoxy-4'-t-
Butyldibenzoylmethane, 5- (3,3-dimethyl-2-norbornylidene) -3-pentan-2-one and the like.
【0042】血行促進剤としては、ノニル酸ワレニルア
ミド,ニコチン酸ベンジルエステル,ニコチン酸β−ブ
トキシエチルエステル,カプサイシン,ジンゲロン,カ
ンタリスチンキ,イクタモール,カフェイン,タンニン
酸,α−ボルネオール,ニコチン酸トコフェロール,イ
ノシトールヘキサニコチネート,シクランデレート,シ
ンナリジン,トラゾリン,アセチルコリン,ベラパミ
ル,セファランチン,γ−オリザノール等が挙げられ
る。Examples of the blood circulation promoter include nonylate valenylamide, nicotinic acid benzyl ester, nicotinic acid β-butoxyethyl ester, capsaicin, zingerone, cantharistinki, ittamol, caffeine, tannic acid, α-borneol, tocopherol nicotinate, Inositol hexanicotinate, cyclanderate, cinnarizine, tolazoline, acetylcholine, verapamil, cepharanthin, γ-oryzanol and the like.
【0043】その他薬剤成分としては、ビタミンA油,
レチノール,パルミチン酸レチノール,イノシット,塩
酸ピリドキシン,ニコチン酸ベンジル,ニコチン酸アミ
ド,ニコチン酸DL−α−トコフェロール,アルコルビ
ン酸リン酸マグネシウム,2−O−α−D−グルコピラ
ノシル−L−アスコルビン酸,ビタミンD2(エルゴカ
シフェロール),dl−α−トコフェロール,酢酸dl
−α−トコフェロール,パントテン酸,ビオチン等のビ
タミン類;エストラジオール,エチニルエストラジオー
ル等のホルモン;アルギニン,アスパラギン酸,シスチ
ン,システイン,メチオニン,セリン,ロイシン,トリ
プトファン等のアミノ酸;アラントイン,アズレン等の
抗炎症剤;アルブチン等の美白剤;酸化亜鉛,タンニン
酸等の収斂剤;L−メントール,カンフル等の清涼剤や
イオウ,塩化リゾチーム,塩化ピリドキシン等が挙げら
れる。Other pharmaceutical ingredients include vitamin A oil,
Retinol, retinol palmitate, inosit, pyridoxine hydrochloride, benzyl nicotinate, nicotinamide, DL-α-tocopherol nicotinate, magnesium phosphate ascorbate, 2-O-α-D-glucopyranosyl-L-ascorbic acid, vitamin D2 (Ergocasiferol), dl-α-tocopherol, acetic acid dl
Vitamins such as α-tocopherol, pantothenic acid and biotin; hormones such as estradiol and ethinyl estradiol; amino acids such as arginine, aspartic acid, cystine, cysteine, methionine, serine, leucine and tryptophan; anti-inflammatory agents such as allantoin and azulene Whitening agents such as arbutin; astringents such as zinc oxide and tannic acid; cooling agents such as L-menthol and camphor; sulfur; lysozyme chloride; pyridoxine chloride;
【0044】各種の抽出液としては、例えばドクダミエ
キス,オウバクエキス,メリロートエキス,オドリコソ
ウエキス,カンゾウエキス,シャクヤクエキス,サボン
ソウエキス,ヘチマエキス,キナエキス,ユキノシタエ
キス,クララエキス,コウホネエキス,ウイキョウエキ
ス,サクラソウエキス,バラエキス,ジオウエキス,レ
モンエキス,シコンエキス,アロエエキス,ショウブ根
エキス,ユーカリエキス,スギナエキス,セージエキ
ス,タイムエキス,茶エキス,海藻エキス,キューカン
バーエキス,チョウジエキス,キイチゴエキス,メリッ
サエキス,ニンジンエキス,マロニエエキス,モモエキ
ス,桃葉エキス,クワエキス,ヤグルマギクエキス,ハ
マメリスエキス,プラセンタエキス,胸腺抽出物,シル
ク抽出液,甘草エキス等が挙げられる。Examples of various extracts include, for example, dokudami extract, oak extract, melilot extract, edible extract, licorice extract, peony extract, saponosa extract, loofah extract, kina extract, saxifrage extract, clara extract, kohone extract, fennel extract, Primrose extract, rose extract, pheasant extract, lemon extract, sicon extract, aloe extract, shobu root extract, eucalyptus extract, horsetail extract, sage extract, thyme extract, tea extract, seaweed extract, cucumber extract, clove extract, raspberry extract, melissa extract, carrot Extract, horse chestnut extract, peach extract, peach leaf extract, mulberry extract, cornflower extract, hamamelis extract, placenta extract, thymus extract, silk extract, licorice extract Etc. The.
【0045】[0045]
【実施例】次に実施例をあげて本発明を説明するが,本
発明の技術的範囲が、これらの実施例によって制限され
るべきものではない。 A.皮膚洗浄料の使用性の評価 カルボキシビニルポリマーとモノアルキルトリメチルア
ンモニウム塩及び/又はジアルキルジメチルアンモニウ
ム塩を含むハイドロゲル組成物について、モノアルキル
トリメチルアンモニウム塩又はジアルキルジメチルアン
モニウム塩のいずれをも含まないハイドロゲル組成物、
並びにノニオン系の増粘剤とモノアルキルトリメチルア
ンモニウム塩及び/又はジアルキルジメチルアンモニウ
ム塩を含むハイドロゲル組成物と比較してその使用性を
評価した。Next, the present invention will be described with reference to examples, but the technical scope of the present invention should not be limited by these examples. A. Evaluation of Usability of Skin Cleanser For hydrogel composition containing carboxyvinyl polymer and monoalkyltrimethylammonium salt and / or dialkyldimethylammonium salt, hydrogel containing neither monoalkyltrimethylammonium salt or dialkyldimethylammonium salt Composition,
The usability was evaluated in comparison with a hydrogel composition containing a nonionic thickener and a monoalkyltrimethylammonium salt and / or a dialkyldimethylammonium salt.
【0046】〔評価方法および評価基準〕女性パネル1
0名により、実施例・比較例それぞれの試料を顔または
体の一部に塗擦し、使用性を比較した。 (1)塗擦している間の垢状の凝集物発生のわかりやす
さ ◎:垢状の凝集物の発生が明確であると答えたパネルが
10名中8名以上 ○:垢状の凝集物の発生が明確であると答えたパネルが
10名中6〜7名 △:垢状の凝集物の発生が明確であると答えたパネルが
10名中3〜5名 ×:垢状の凝集物の発生が明確であると答えたパネルが
10名中2名以下[Evaluation Method and Evaluation Criteria] Female Panel 1
The sample of each of Examples and Comparative Examples was rubbed on the face or a part of the body by 0 persons, and the usability was compared. (1) Easiness of formation of slime-like aggregates during rubbing ◎: Eight or more panelists answered that the occurrence of slime-like aggregates was clear ○: Generation of slime-like aggregates 6 to 7 out of 10 panelists answered that was clear Δ: 3 to 5 out of 10 panels answered that generation of plaque-like agglomerates ×: generation of plaque-like agglomerates No more than 2 out of 10 panelists answered that the question was clear
【0047】(2)洗い流した後の感覚的洗浄効果 ◎:皮膚の汚れがよく落ちたと答えたパネルが10名中
8名以上 ○:皮膚の汚れがよく落ちたと答えたパネルが10名中
6〜7名 △:皮膚の汚れがよく落ちたと答えたパネルが10名中
3〜5名 ×:皮膚の汚れがよく落ちたと答えたパネルが10名中
2名以下(2) Sensory cleaning effect after rinsing A: Eight or more out of ten panelists answered that skin dirt was well removed O: Six out of ten panelists answered that skin dirt was well removed ~ 7 panelists: 3 to 5 panelists answered that skin dirt was removed well x: 2 panel panelists answered that skin dirt was removed well.
【0048】(3)洗い流した後の皮膚感覚 ◎:なめらかであると答えたパネルが10名中8名以上 ○:なめらかであると答えたパネルが10名中6〜7名 △:なめらかであると答えたパネルが10名中3〜5名 ×:なめらかであると答えたパネルが10名中2名以下(3) Skin sensation after rinsing A: 8 out of 10 panelists answered that it was smooth ○: 6 to 7 panelists answered that it was smooth Δ: Smooth 3 to 5 panelists out of 10 answered ×: 2 or less panelists answered that they were smooth
【0049】第1表及び第2表に記載した処方の皮膚洗
浄料を調製し、その使用性の評価を行った。 第 1 表 (基本処方) ────────────────────────────────── ジプロピレングリコール 5.0 重量% POE(60)硬化ヒマシ油 0.5 グリセリン 1.0 ジメチルポリシロキサン 2.0 メチルパラベン 0.2 香料 0.05 増粘剤 下 記 カチオン 下 記 イオン交換水 残 余 ────────────────────────────────── 以上の基本処方で、増粘剤およびカチオンを第2表の各
成分に置き換えた皮膚洗浄料を調製して評価を行った。
結果を併せて第2表に示す。[0049] Skin cleansers having the formulations shown in Tables 1 and 2 were prepared, and their usability was evaluated. Table 1 (Basic prescription) ────────────────────────────────── Dipropylene glycol 5.0% by weight POE (60) Hardened castor oil 0.5 Glycerin 1.0 Dimethyl polysiloxane 2.0 Methyl paraben 0.2 Perfume 0.05 Thickener The following cation The following ion-exchanged water balance皮膚 Prepare a skin cleanser with the above basic formula, replacing the thickener and cation with the components shown in Table 2. Was evaluated.
Table 2 also shows the results.
【0050】[0050]
【表2】 [Table 2]
【0051】なお、上記のカルボキシビニルポリマーと
してはハイビスワコー104(和光純薬社製)を用い
た。The carboxyvinyl polymer used was Hibiswako 104 (manufactured by Wako Pure Chemical Industries, Ltd.).
【0052】上の結果により、カルボキシビニルポリマ
ー並びにモノアルキルトリメチルアンモニウム塩及び/
又はジアルキルジメチルアンモニウム塩を含むハイドロ
ゲル組成物については,皮膚に塗擦した際に垢状の凝集
物が発生し,感覚的な皮膚の汚れの除去効果に優れ、洗
い流した後の皮膚状態が滑沢性に優れるのに対して、モ
ノアルキルトリメチルアンモニウム塩又はジアルキルジ
メチルアンモニウム塩のいずれも含まないハイドロゲル
組成物、及び増粘剤としてノニオン系のメチルセルロー
スやヒドロキシプロピルエチルセルロースを用いてモノ
アルキルトリメチルアンモニウム塩及び/又はジアルキ
ルジメチルアンモニウム塩と組み合わせたハイドロゲル
組成物は垢状の凝集物の発生もなく、感覚的洗浄効果や
洗い流し後の滑らかさもいずれもが劣ることがわかる。The above results show that the carboxyvinyl polymer and the monoalkyltrimethylammonium salt and / or
Alternatively, a hydrogel composition containing a dialkyldimethylammonium salt produces slime-like aggregates when rubbed on the skin, has an excellent sensory skin dirt removing effect, and has a smooth skin condition after rinsing. Although excellent in properties, a hydrogel composition containing neither a monoalkyltrimethylammonium salt or a dialkyldimethylammonium salt, and a monoalkyltrimethylammonium salt using nonionic methylcellulose or hydroxypropylethylcellulose as a thickener and It can be seen that the hydrogel composition combined with / or a dialkyldimethylammonium salt does not generate slime-like aggregates and is inferior in both the sensory cleaning effect and the smoothness after rinsing.
【0053】以下、本発明皮膚洗浄料の他の処方を実施
例として表す。 〔実施例6〕 (配合成分) 配合量(重量%) (1)ジプロピレングリコール 5.0 (2)グリセリン 3.0 (3)カルボキシビニルポリマー 1.0 〔ハイビスワコー103(和光純薬社製)〕 (4)キサンタンガム 0.1 (5)ヒドロキシプロピルメチルセルロース 1.5 (6)セチルトリメチルアンモニンム臭化物 0.5 (7)ジラウリルジメチルアンモニウム塩化物 0.5 (8)ソルビタンモノオレイン酸エステル 1.0 (9)ワセリン 1.0 (10)流動パラフィン 5.0 (11)グリセロールトリ−2−エチル ヘキサン酸エステル 2.0 (12)ジメチルポリシロキサン(6cs) 5.0 (13)エチルパラベン 0.2 (14)香料 0.05 (15)イオン交換水 残余Hereinafter, other formulations of the skin cleanser of the present invention will be described as examples. [Example 6] (Blending components) Blending amount (% by weight) (1) Dipropylene glycol 5.0 (2) Glycerin 3.0 (3) Carboxyvinyl polymer 1.0 [Hibiswako 103 (manufactured by Wako Pure Chemical Industries, Ltd.) (4) Xanthan gum 0.1 (5) Hydroxypropyl methylcellulose 1.5 (6) Cetyltrimethylammonium bromide 0.5 (7) Dilauryldimethylammonium chloride 0.5 (8) Sorbitan monooleate 1 0.0 (9) Vaseline 1.0 (10) Liquid paraffin 5.0 (11) Glycerol tri-2-ethyl hexanoate 2.0 (12) Dimethyl polysiloxane (6cs) 5.0 (13) Ethyl paraben 0 .2 (14) Fragrance 0.05 (15) Deionized water residue
【0054】常法により皮膚洗浄料を調製した。得られ
た皮膚洗浄料は、皮膚に塗擦した際に垢状の凝集物が発
生し、感覚的な皮膚の汚れの除去効果にすぐれ、洗い流
したあとに滑沢性にすぐれた皮膚状態が得られるもので
あった。A skin cleanser was prepared by a conventional method. The resulting skin cleanser produces scaly agglomerates when rubbed on the skin, has an excellent sensory skin dirt removal effect, and has a lubricated skin condition after being rinsed off. Was something.
【0055】 〔実施例7〕 (配合成分) 配合量(重量%) (1)エチルアルコール 5.0 (2)プロピレングリコール 2.0 (3)カルボキシビニルポリマー 2.5 〔カーボポール980(BFGoodrich社製)〕 (4)カルボキシメチルセルロース 0.1 (5)ミリスチルトリメチルアンモニンム臭化物 2.0 (6)エデト酸3ナトリウム 0.05 (7)ポリオキシエチレン 変性ジメチルポリシロキサン 0.5 (8)オクタメチルシクロテトラシロキサン 1.0 (9)メチルパラベン 0.1 (10)香料 0.01 (11)イオン交換水 残余[Example 7] (Blending components) Blending amount (% by weight) (1) Ethyl alcohol 5.0 (2) Propylene glycol 2.0 (3) Carboxyvinyl polymer 2.5 [Carbopol 980 (BF Goodrich) (4) Carboxymethylcellulose 0.1 (5) Myristyltrimethylammonium bromide 2.0 (6) Trisodium edetate 0.05 (7) Polyoxyethylene-modified dimethylpolysiloxane 0.5 (8) Octamethyl Cyclotetrasiloxane 1.0 (9) Methyl paraben 0.1 (10) Fragrance 0.01 (11) Deionized water residue
【0056】常法により皮膚洗浄料を調製した。得られ
た皮膚洗浄料は、皮膚に塗擦した際に垢状の凝集物が発
生し、感覚的な皮膚の汚れの除去効果にすぐれ、洗い流
したあとに滑沢性にすぐれた皮膚状態が得られるもので
あった。A skin cleanser was prepared by a conventional method. The resulting skin cleanser produces scaly agglomerates when rubbed on the skin, has an excellent sensory skin dirt removal effect, and has a lubricated skin condition after being rinsed off. Was something.
【0057】 〔実施例8〕 (配合成分) 配合量(重量%) (1)1,3−ブチレングリコール 6.0 (2)PEG 1500 4.0 (3)POE(25)セチルアルコールエーテル 2.0 (4)モノステアリン酸グリセリン 1.0 (5)ステアリルアルコール 1.0 (6)固体パラフィン 1.0 (7)ワセリン 3.0 (8)スクワラン 5.0 (9)ブチルパラベン 0.2 (10)ジメチルポリシロキサン(20cs) 3.0 (11)香料 0.3 (12)カルボキシビニルポリマー 0.5 〔ハイビスワコー105(和光純薬社製)〕 (13)ベヘニルトリメチルアンモニウム塩化物 0.1 (14)イオン交換水 残余Example 8 (Blending components) Blending amount (% by weight) (1) 1,3-butylene glycol 6.0 (2) PEG 1500 4.0 (3) POE (25) cetyl alcohol ether 0 (4) Glycerin monostearate 1.0 (5) Stearyl alcohol 1.0 (6) Solid paraffin 1.0 (7) Vaseline 3.0 (8) Squalane 5.0 (9) Butylparaben 0.2 ( 10) Dimethylpolysiloxane (20cs) 3.0 (11) Fragrance 0.3 (12) Carboxyvinyl polymer 0.5 [Hibiswako 105 (manufactured by Wako Pure Chemical Industries)] (13) Behenyltrimethylammonium chloride 0.1 (14) Ion exchange water residue
【0058】常法により皮膚洗浄料を調製した。得られ
た皮膚洗浄料は、皮膚に塗擦した際に垢状の凝集物が発
生し、感覚的な皮膚の汚れの除去効果にすぐれ、洗い流
したあとに滑沢性にすぐれた皮膚状態が得られるもので
あった。A skin cleanser was prepared by a conventional method. The resulting skin cleanser produces scaly agglomerates when rubbed on the skin, has an excellent sensory skin dirt removal effect, and has a lubricated skin condition after being rinsed off. Was something.
【0059】[0059]
【発明の効果】本発明により、皮膚の汚れの除去効果に
優れ,洗い流した後や拭き取った後の皮膚状態が滑沢性
にも優れると共に、汚れが除去される過程がより視覚的
に実感され得る、皮膚に塗擦した際に垢状の凝集物が発
生する皮膚洗浄料が提供される。According to the present invention, the effect of removing skin stains is excellent, the skin condition after rinsing and wiping is excellent in lubricity, and the process of removing stains can be visually realized. Thus, there is provided a skin cleansing agent which produces slime-like aggregates when rubbed on the skin.
Claims (5)
キルトリメチルアンモニウム塩及び/又はジアルキルジ
メチルアンモニウム塩を含んでなる皮膚洗浄料。1. A skin cleanser comprising a carboxyvinyl polymer and a monoalkyltrimethylammonium salt and / or a dialkyldimethylammonium salt.
ボキシビニルポリマー並びにモノアルキルトリメチルア
ンモニウム塩及び/又はジアルキルジメチルアンモニウ
ム塩が接触して形成されるゲルのpHが3以下である皮
膚洗浄料。2. The skin cleanser according to claim 1, wherein the gel formed by contacting the carboxyvinyl polymer and the monoalkyltrimethylammonium salt and / or the dialkyldimethylammonium salt has a pH of 3 or less.
び/又はジアルキルジメチルアンモニウム塩を構成する
アルキル基の炭素数が12以上22以下である、請求項
1又は請求項2記載の皮膚洗浄料。3. The skin cleanser according to claim 1, wherein the alkyl group constituting the monoalkyltrimethylammonium salt and / or the dialkyldimethylammonium salt has 12 to 22 carbon atoms.
記載の皮膚洗浄料において、カルボキシビニルポリマー
の配合量が皮膚洗浄料の0.3重量%以上,5.0重量
%以下である皮膚洗浄料。4. The skin cleanser according to any one of claims 1 to 3, wherein the amount of the carboxyvinyl polymer is from 0.3% by weight to 5.0% by weight of the skin cleanser. Some skin cleansers.
記載の皮膚洗浄料において、モノアルキルトリメチルア
ンモニウム塩及び/又はジアルキルジメチルアンモニウ
ム塩の総配合量が皮膚洗浄料の0.1重量%以上,3.
0重量%以下である皮膚洗浄料。5. The skin cleanser according to claim 1, wherein the total amount of the monoalkyltrimethylammonium salt and / or the dialkyldimethylammonium salt is 0.1% by weight of the skin cleanser. % Or more;
A skin cleanser that is 0% by weight or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9530697A JPH10273434A (en) | 1997-03-30 | 1997-03-30 | Skin cleaner |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9530697A JPH10273434A (en) | 1997-03-30 | 1997-03-30 | Skin cleaner |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10273434A true JPH10273434A (en) | 1998-10-13 |
Family
ID=14134090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9530697A Withdrawn JPH10273434A (en) | 1997-03-30 | 1997-03-30 | Skin cleaner |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH10273434A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007119437A (en) * | 2005-10-27 | 2007-05-17 | Estate Chemical Kk | Gommage cosmetic |
JP2008001627A (en) * | 2006-06-22 | 2008-01-10 | Sansho Kaken Kk | Skin cleaner |
JP2008222641A (en) * | 2007-03-13 | 2008-09-25 | Sansho Kaken Kk | Skin cleaner |
JP2008255019A (en) * | 2007-04-02 | 2008-10-23 | Sansho Kaken Kk | Skin cleaner |
JP2016175877A (en) * | 2015-03-20 | 2016-10-06 | 三粧化研株式会社 | Spray type skin detergent |
JP2016175878A (en) * | 2015-03-20 | 2016-10-06 | 三粧化研株式会社 | Skin detergent |
JP2020007303A (en) * | 2018-06-27 | 2020-01-16 | 小林製薬株式会社 | Skin cleanser composition |
-
1997
- 1997-03-30 JP JP9530697A patent/JPH10273434A/en not_active Withdrawn
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007119437A (en) * | 2005-10-27 | 2007-05-17 | Estate Chemical Kk | Gommage cosmetic |
JP2008001627A (en) * | 2006-06-22 | 2008-01-10 | Sansho Kaken Kk | Skin cleaner |
JP2008222641A (en) * | 2007-03-13 | 2008-09-25 | Sansho Kaken Kk | Skin cleaner |
JP2008255019A (en) * | 2007-04-02 | 2008-10-23 | Sansho Kaken Kk | Skin cleaner |
JP2016175877A (en) * | 2015-03-20 | 2016-10-06 | 三粧化研株式会社 | Spray type skin detergent |
JP2016175878A (en) * | 2015-03-20 | 2016-10-06 | 三粧化研株式会社 | Skin detergent |
JP2020007303A (en) * | 2018-06-27 | 2020-01-16 | 小林製薬株式会社 | Skin cleanser composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6136043B1 (en) | Ripple phase-containing composition, α-gel-forming composition, and external composition for skin and α-gel composition using the same | |
JP5305574B2 (en) | Topical skin preparation | |
US20100075882A1 (en) | External Skin Preparation And Skin Cleanser | |
JP3523009B2 (en) | Aqueous thickened gel composition and liquid oil-in-water emulsion composition | |
JPH09301847A (en) | Low viscosity water in oil-type emulsified composition and dermal agent for external use using the same | |
JP2000087081A (en) | Detergent composition | |
JPH10273434A (en) | Skin cleaner | |
JP5530052B2 (en) | Skin cleanser | |
JP2003221310A (en) | Skin cleanser | |
JPH1160436A (en) | Cosmetic for improving chapped skin | |
JPH09255523A (en) | Cosmetic | |
JP6426635B2 (en) | Composition for alpha gel formation and alpha gel composition | |
JP7507604B2 (en) | Cosmetics | |
JPH09263527A (en) | Preparation for external use for skin | |
JP7506977B2 (en) | Cleansing agent | |
JPH09263530A (en) | Emulsion composition | |
JP2002121131A (en) | Detergent having stable pearly feeling | |
JPH1160435A (en) | Cosmetic for improving chapped skin | |
JP5154904B2 (en) | Topical skin preparation | |
JPH11130650A (en) | Desmosome decomposition promoter and horny layer releasing agent | |
JPH11106325A (en) | Skin lotion | |
JP2009143817A (en) | Skin cleanser | |
JPH10245318A (en) | Gelatinized composition and gelatinized cosmetic | |
JPH11228380A (en) | Cosmetic for improving chapped skin | |
JPH11228335A (en) | Cosmetic for controlling sebum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20040601 |